Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q3 2015 · 10-Q
Revenue$118.19K$118.19K−72.8% vs Q3 2014 Net Income-$697.47K-$697.47KN/M vs Q3 2014 EPS Diluted$0.00$0.00— vs Q3 2014 Operating Income-$506,326— Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
derived
Margins · derivedOperating margin-428.4%
Net margin-590.1%−501.7 pt vs Q3 2014
ended Sep 30, 2015 · filed Nov 16, 2015 · 47 d after period end